| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.0003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |